hexamethonium has been researched along with Female Genital Neoplasms in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JT | 1 |
| Hirai, Y | 1 |
| Hamada, T | 1 |
| Fujimoto, I | 1 |
| Yamauchi, K | 1 |
| Hasumi, K | 1 |
| Masubuchi, K | 1 |
1 other study available for hexamethonium and Female Genital Neoplasms
| Article | Year |
|---|---|
[Medical vagotomy: a new effective antiemetic therapy in cisplatin-induced nausea and vomiting].
Topics: Adult; Atropine; Cisplatin; Female; Genital Neoplasms, Female; Hexamethonium; Hexamethonium Compound | 1987 |